# Short Course of Interferon Treatment in Patients With HCV Infection

> **NCT00502970** · PHASE4 · COMPLETED · sponsor: **Aga Khan University** · enrollment: 150 (actual)

## Conditions studied

- Hepatitis C
- Chronic Disease
- Treatment

## Interventions

- **DRUG:** 16 weeks Interferon Tiw with Ribavirin
- **DRUG:** 24 weeks Interferon

## Key facts

- **NCT ID:** NCT00502970
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2008-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00502970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00502970, "Short Course of Interferon Treatment in Patients With HCV Infection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00502970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*